Gout, a chronic illness characterised by hyperuricaemia (elevation of serum uric acid (SUA) levels), arthropathy, tophus development, and urolithiasis, is associated with an increased risk of cardiovascular and chronic kidney disease. The risk of cardiovascular events, including death, is substantially higher in people with gout than in those without gout.

As our understanding of the pathophysiology and risk factors of gout has widened, multiple treatment methodologies for its management have emerged [Image: Shutterstock].

Please sign in to read more